SCHEMBL30199144

SCHEMBL30199144

N#Cc1ccc(COc2ccc3c(c2)CNCC3)c(F)c1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 2/20 0.57
▸ DRD3 P35462 2/20 0.57
▸ PNMT P11086 2/20 0.57
▸ CD274 Q9NZQ7 1/20 0.44
▸ HRH3 Q9Y5N1 3/20 0.44
▸ ADRA2A P08913 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ PRMT5 O14744 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ MAOA P21397 2/20 0.38
▸ MAOB P27338 2/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ SCN3A Q9NY46 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30199396 1.00 DRD2 (0.57) DRD2DRD3PNMTCD274HRH3
SCHEMBL29097839 1.00 DRD2 (0.57) DRD2DRD3PNMTCD274HRH3
SCHEMBL29097955 0.95 DRD2 (0.57) DRD2DRD3PNMTCD274HRH3
SCHEMBL30199147 0.95 DRD2 (0.57) DRD2DRD3PNMTCD274HRH3
SCHEMBL30199135 0.86 PNMT (0.44) DRD2DRD3PNMTCD274PRMT5
SCHEMBL29098094 0.86 PNMT (0.44) DRD2DRD3PNMTCD274PRMT5
SCHEMBL29098052 0.82 DRD2 (0.60) DRD2DRD3PNMTHRH3ADRA2A
SCHEMBL30199515 0.82 CD274 (0.57) PNMTCD274HRH3ADRA2AADRA2B
SCHEMBL30199078 0.82 DRD2 (0.60) DRD2DRD3PNMTHRH3ADRA2A
SCHEMBL29097827 0.82 CD274 (0.57) PNMTCD274HRH3ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115594669-B Parallel ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司 2024-11-05 — — CN disclosed
CN-115594669-A Fused ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司(CN) 2023-01-13 — — CN disclosed
Send feedback